Real-life cost-effectiveness of benralizumab in patients with severe asthma
Respiratory research, 2021-05, Vol.22 (1), p.163-163, Article 163 [Peer Reviewed Journal]COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1465-993X ;ISSN: 1465-9921 ;EISSN: 1465-993X ;DOI: 10.1186/s12931-021-01758-0 ;PMID: 34044819
Full text available